Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro

Cancer Lett. 2009 Apr 18;276(2):160-70. doi: 10.1016/j.canlet.2008.11.004. Epub 2008 Dec 17.

Abstract

Microtubules are long-standing targets in cancer chemotherapy. Previously, we reported that marchantin C triggers apoptosis of human tumor cells. We show here that marchantin C induced cell cycle arrest at G(2)/M phase in A172 and HeLa cells. In addition, marchantin C decreased the quantity of microtubules in a time- and dose-dependent manner in these cells. Exposure of purified bovine brain tubulin to marchantin C inhibited polymerization of gross tubulin in vitro. Moreover, marchantin C potently suppressed the growth of human cervical carcinoma xenografts in nude mice. Marchantin C-treated xenografts showed decreased microtubules, Bcl-2 and increased cyclin B1, Bax, caspase-3, indicating that marchantin C possess the same ability to induce microtubules depolymerization and tumor cell apoptosis in tumor-bearing mice as in vitro. In conclusion, marchantin C is a novel microtubule inhibitor that induces mitotic arrest of tumor cells and suppresses tumor cell growth, exhibiting promising antitumor therapeutic potential.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Bibenzyls / pharmacology*
  • Catechols / pharmacology*
  • Cell Division / drug effects
  • Cell Line, Tumor
  • Ethers, Cyclic / pharmacology*
  • Female
  • G2 Phase / drug effects
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Microtubules / drug effects*
  • Microtubules / metabolism
  • Phenyl Ethers / pharmacology*
  • Uterine Cervical Neoplasms / drug therapy
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents, Phytogenic
  • Bibenzyls
  • Catechols
  • Ethers, Cyclic
  • Phenyl Ethers
  • marchantin C